Accretive Health delivers end-to-end revenue cycle management services to healthcare providers, with a focus on maximizing cash creation through yield improvements instead of traditional revenue cycle measures. Accretive's quality and total cost of care service offering helps providers effectively manage the health of a defined patient population.
Advanced Practice Strategies provides e-learning solutions for providers and payers seeking to increase patient safety and better manage liability exposure in high-risk areas. The company also provides litigation support services to providers, leveraging its medical illustration expertise to develop visual strategies that educate the jury in complex medical and technical matters.
Aethon is a logistics and workflow solutions company that manufactures an autonomous mobile robot that automates supply chain across a broad range of functions including pharmacy, supplies, meals, linen, and waste removal. Its solutions help hospitals to lower costs, optimize processes, improve asset utilization, and ensure regulatory compliance.
Apama Medical is a privately held medical device company formed by Shifamed LLC, a Silicon Valley based medical device incubator. Apama is focused on the rapidly growing electrophysiology (EP) market in which mapping and ablation is estimated to reach $2.0B in 2017.
Atigeo is a compassionate technology company for a wiser world. The xPatterns™ platform, Atigeo’s flagship big data analytics product, generates knowledge from all available data and empowers healthcare organizations and other industries to discover previously unforeseen insights, predict outcomes, and mitigate risks.
Bardy Diagnostics, Inc. ("BardyDx") was founded to address a longstanding complaint in cardiac arrhythmia monitoring that current monitors are large, bulky, uncomfortable and frequently record noisy QRS signals. BardyDx has responded to this complaint by providing a solution Ã¢â‚¬â€œ the Carnation Ambulatory Monitor, a non-invasive P-wave centricÃ¢â€Å¾Â¢ ambulatory cardiac monitor and arrhythmia detection device that generates superior clinical data, improves patient compliance and fits within varied hospital and cardiology workflows and reimbursement concerns.
BioImagene was acquired by Ventana Medical Systems in 2010, a member of the Roche Group. BioImagene provided innovative and scalable digital pathology solutions for clinical diagnostics and drug discovery.
CB Health Ventures
CB Health Ventures is a healthcare focused venture firm with two funds under management. It is no longer actively investing in new companies.
Cheetah Medical's proprietary NICOM Noninvasive Cardiac Output and Hemodynamic Monitoring System delivers continuous, accurate parameters useful for fluid management and drug titration. The system is FDA-cleared and CE Marked, and since its commercial launch in 2008 has been adopted by a growing number of clinicians worldwide.
CHF Solutions was acquired by Gambro in 2010. The company manufactured innovative medical devices for cardiac care and was the developer of Aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system, a method to remove excess fluid from patients suffering from fluid overload.
Confluent Surgical was acquired by Tyco International in 2006. The company pioneered the development and delivery of biomaterials to be used as sealants, for adhesion prevention and homeostasis in many types of surgery.
CSA Medical, Inc. develops and manufactures a proprietary interventional spray cryotherapy technology platform comprised of a device and specialty catheters that enable delivery of spray cryogen inside the body to flash freeze and destroy unwanted tissue. The Company is the first to harness the power of low pressure, extremely cold (-196 o C) liquid nitrogen inside the body.
EKOS Corporation is the world leader in providing ultrasound-assisted, fluid infusion catheters for treating blood clots. Other applications which deliver physician-prescribed fluids or contrast agent to other targeted locations in the body are under investigation.
Emageon (NASD: EMAG) completed an initial public offering in 2005 and was subsequently acquired by Amicas, Inc. Emageon provided DICOM standard visualization, archiving and workflow software used to manage images and create an enterprise visual medical record.
Essex Woodlands Funds VI and VII are AHV Fund I portfolio companies.
Essex Woodlands Fund VIII is an AHV Fund II portfolio company.
Essex Woodlands is one of the oldest and most respected healthcare growth equity and venture capital firms in the world. The firm has $2.5 billion under management and is currently investing out of its eighth fund. The majority of capital is allocated to growth equity with a minority targeted towards traditional venture capital investments.
Excel Venture Management builds companies that apply transformative technologies to solve problems in healthcare and beyond. The Excel investment portfolio is balanced across healthcare IT and services, diagnostics, and medical devices, plus life science platforms that address adjacent markets including energy, chemicals, defense and agriculture.
GetWellNetwork, Inc.® provides patient engagement solutions that help healthcare providers engage, educate and empower patients along the care continuum. Our patient-centered platform, delivered across multiple technology platforms including mobile devices, computers and televisions, enables providers to implement a revolutionary care delivery model called Interactive Patient Care™ to improve performance and patient outcomes. The company further extends the value of existing IT investments by integrating seamlessly with electronic medical record and patient portal applications. GetWellNetwork is recognized by KLAS® as the leader in the Interactive Patient Systems category and exclusively endorsed by the American Hospital Association.
Haven Behavioral Healthcare provides quality behavioral healthcare, for not only patients, but families and communities as well. Areas of expertise include geriatric psychiatry, adult psychiatry, chemical dependency, a highly specialized military program for those in active service, as well as providing one of the world's foremost treatment programs for eating disorders.
Hemosphere was acquired by CryoLife in 2005 and subsequently acquired by Merit Medical Systems. The company was an early stage medical device developer of a vascular access technology for hemodialysis.
Impulse Monitoring was acquired by NuVasive, Inc. (NASD: NUVA) in 2011. Impulse Monitoring provides surgical support services to hospitals and other facilities that include intraoperative neuromonitoring (IONM) for spinal, nerve and brain-related surgeries.
Ingenious Med provides the leading patient encounter platform, a cloud based, Web and mobile point-of-care solution that automates the workflow of care teams in the areas of care coordination, charge capture, and advanced analytics. Ingenious Med continues to break new ground, developing useful, useable solutions to increase the quality of care, protect and bolster revenue, and most importantly of all, put physicians’ time where it is needed most: with their patients.
Ivantis, Inc. is a company dedicated to the development of new and innovative solutions for glaucoma. Current therapies for primary open angle glaucoma (POAG) include eye drops, laser therapy, and surgery. But each of these has its limitations. Glaucoma remains the leading cause of blindness worldwide, in need of better treatment alternatives. Ivantis’ goal is to develop new and effective solutions for ophthalmology specialists and the 70 million people worldwide who are affected by this debilitating and sight-stealing disease.
MedVentive was acquired by McKesson (NYSE:MCK) in 2012 and is part of that larger organization. MedVentive is a leader in risk management and population management solutions for provider organizations and managed care plans.
NaviHealth partners with health plans, health systems and post-acute providers to manage the entire continuum of post-acute care. The company utilizes evidence-based protocols to optimize care and bundled payment methodologies to align all stakeholders. The result: optimized care and outcomes, reduced inpatient days, reduced hospital readmissions, and increased patient satisfaction.
Neurolutions is developing brain computer interface technology that uses non-invasive technology to detect brain waves to control movement of prostheses. The company is pursuing the stroke rehabilitation market.
Novasys Medical, Inc. is a privately held, venture-backed company which develops innovative therapies in women’s health. The company’s Renessa System is a proprietary, non-surgical approach to the treatment of stress urinary incontinence (SUI) in women.
Ob Hospitalist Group (“OBHG”) is the leading provider of obstetrics (“OB”) hospitalist programs to hospitals in the US. OBHG’s solutions are focused on providing customized 24/7 OB emergency care as well as OB-related emergency care and general Ob inpatient management.
Ocular Therapeutix(NASD:OCUL) is developing and commercializing ophthalmic therapeutic products using its proprietary hydrogel technology. The Company is commercializing its ReSureTM Adherent Ocular Bandage for surgical applications and is developing sustained ocular drug delivery products based on its core hydrogel technology. The Company completed an IPO in 2014.
Omnicell is a leading supplier of comprehensive automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
PathoGenetix, Inc. (formerly U.S. Genomics) is developing an automated system for identification and strain typing of pathogens in a broad range of complex sample types. Unlike approaches that require specific reagents for detection of each pathogen, PathoGenetix' approach uses a single reagent set to create genomic barcodes which are then used to detect and identify thousands of strains from hundreds of species.
Phreesia is the national leader in patient check-in. By automating patient intake, Phreesia allows medical practices to conveniently effortlessly collect comprehensive patient information, verify insurance in real time, and collect payments both at the point of care and outside of the office. Phreesia delivers fully interactive content direct to patients and is designed to interface with clinicians' existing and future technology. Phreesia is committed to enhancing the patient experience and enabling clinicians to stay at the forefront of patient care.
Quantros is a leading provider of software and services to advance patient safety and healthcare quality performance. Its Software-as a-Service (SaaS)-based applications help over 2,000 healthcare facilities improve their care environment, risk management and financial performance.
Radianse is the leading provider of Real Time Location Systems (RTLS) for healthcare, providing comprehensive intelligent solutions built on a solid foundation proven to deliver accuracy, scalability and reliability.
Reputation.com delivers an all-in-one SaaS platform that helps businesses:
• Monitor and respond to patient feedback easily -- on Google, Facebook, Yelp and dozens of specialty review sites -- from a single platform
• Request reviews and surveys from all patients, via browser, mobile or SMS -- to generate more representative star ratings and reviews
• Operate better -- identifying ways to improve the patient experience -- to drive retention, repeat visits and revenue
The company created the Online Reputation Management category in 2006, and now helps over 224,000 locations and professionals in 77 industries manage over 20 million reviews, enlist the voice of the patient, and attract more business
Sanderling Ventures is among the oldest investment firms dedicated to building new biomedical companies. Sanderling's unique approach combines a specialized investment focus with active management and long-term commitment to ensure the highest rates of return for both its entrepreneurs and investors.
Solstas Lab Partners is one of the 10 largest full-service laboratories in the U.S., supporting the unique needs of clients and their patients with a full range of clinical, anatomic and esoteric testing services. Its mission is to create value in patient care through provider-focused delivery of clinical information and diagnostic services.
Stereotaxis (NASD: STXS) completed an initial public offering in 2004. The company is a developer of an innovative catheter navigation platform designed to make the treatment of complex cardiac arrhythmias safe and effective.
SterilMed was acquired by Ethicon Endo-Surgery, a subsidiary of Johnson & Johnson (NYSE: JNJ). The company specializes in medical device reprocessing and small equipment & instrument repair for hospitals and healthcare facilities.
SV Life Sciences (SVLS) is a leading international life sciences venture capital firm. The SVLS team manages five private venture capital funds with approximately $2.0 billion of capital under management. The firm employs a diversified strategy within life sciences in order to selectively capitalize on an expanding opportunity in biotech, medical devices and health-care services.
Syapse provides a Precision Medicine Platform, which is a comprehensive software suite used by leading academic and community health systems to support the clinical implementation of oncology precision medicine. This category-defining platform enables clinical and genomic data integration, decision support, care coordination, and quality improvement at point-of-care.
TomoTherapy (NASD: TOMO) completed an initial public offering in 2007 and was later acquired by Accuray (NASD: ARAY). The company provides a revolutionary, radiation treatment system that delivers conformal radiation therapy to cancer patients while limiting damage to surrounding healthy tissues.
Vascular Pathways, Inc. is a privately-held medical device company focused on commercializing the Accucath Intravenous Catheter System, an FDA approved innovative product enabling rapid, safe, and successful IV insertion.
The Vivify remote care management platform empowers hospitals, home health agencies, and other stakeholders to accomplish population health objectives, including reducing readmissions, managing chronic disease, improving care transitions, and engaging patients in their own well-being. The SaaS platform delivers direct-to-consumer care, including customized care plans, coaching, educational video content, and interactive videoconferencing and aggregates in-home health status and vital signs, automatically transmitting that data to providers and caregivers.
Voalte develops smartphone alternatives that simplify caregiver communication. As the only company to offer a comprehensive Mobile Communication Strategy, Voalte enables care teams inside and outside the hospital to access and exchange information securely. Voalte customers benefit from a solid smartphone infrastructure that supports their existing systems and expands to accommodate future technologies.
Zipnosis provides health systems with a white-labeled, fully integrated telemedicine platform, treating patients through video, telephone, adaptive online interviews, and smart triage – complete with available pharmacy and lab integration.